Evgen Limited
Liverpool Science Park IC1
131 Mount Pleasant
Liverpool L3 5TF
Please direct all enquiries to enquiries@evgen.com
Pioneering the clinical development of sulforaphane for the prevention and treatment of human disease
Press releases
19 September 2011
Evgen set to develop pharmaceutical for patients with early stage prostate cancer
13 September 2011
Merseyside pharmaceutical firm secures Series A investment package
14 December 2010
University of Copenhagen awarded €1.8m grant to establish glucoraphanin fermentation technology
23 September 2010
Stabilised Sulforaphane Patent to be granted in United States
2 March 2010
Evgen and Kraft Foods enter into Option Agreement
4 February 2010
Evgen, PharmAgra Labs and Lalilab enter into Option Agreement
2 November 2009
Please direct all enquiries to enquiries@evgen.com
Company Registration Number : 06403643